The Food and Drugs Authority (FDA) has announced the appointment of Professor Kwabena Frimpong-Manso Opuni as its new Acting Chief Executive Officer, effective Monday, July 14, 2025.
Prior to his appointment, Prof. Opuni served as the Board Chairman of the FDA and brings a wealth of experience to his new role.
He takes over from Dr. Delese Mimi Darko, who has led the Authority since 2017. Dr. Darko was recently appointed as the Director General of the Africa Medicines Agency (AMA).
In a public statement, the FDA congratulated Prof. Opuni and expressed confidence in his ability to steer the institution forward.
“We look forward to his leadership in advancing the Authority’s mandate of safeguarding public health and safety,” the statement read.
